Paying research subjects: participants' perspectives

Objective—To explore the opinions of unpaid healthy volunteers on the payment of research subjects. Design—Prospective cohort. Setting—Southern Alberta, Canada. Participants—Medically eligible persons responding to recruiting advertisements for a randomised vaccine trial were invited to take part in a study of informed consent at the point at which they formally consented or refused trial participation. Of 72 invited, 67 (62 trial consenters, 5 trial refusers) returned questionnaires at baseline and 54 at follow-up. Outcome measures—Proportions of persons who agreed or disagreed with three close-ended statements on the payment of research subjects; themes and categories identified by content analysis of responses to an open-ended question. Results—A minority (43.3%) agreed with paying either patient or healthy volunteer participants. Opinions did not change over time. Participants' comments addressed: benefits and drawbacks to research participation; benefits and drawbacks to paying research participants; conditions under which payment of research subjects would be acceptable, and the nature of acceptable recognition. Acceptable conditions were to improve problematic recruitment, to reimburse costs, and to recognise participants, particularly for their time investment. Both non-monetary and monetary recognition of volunteers were thought to be appropriate. Conclusions—Most unpaid volunteers disagreed with paying research participants. The themes arising from their comments are similar to those that have been raised by ethicists and suggest that recognising the time and effort of participants should receive greater emphasis than presently occurs. (Journal of Medical Ethics 2000;26:126–130)

[1]  A. Pheley,et al.  Motivation for participation in clinical trials of drugs for the treatment of asthma, seasonal allergic rhinitis, and perennial nonallergic rhinitis. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[2]  H. Searight,et al.  Remembering and Interpreting Informed Consent: A Qualitative Study of Drug Trial Participants , 1996, The Journal of the American Board of Family Medicine.

[3]  L. D. D. Castro EXPLOITATION IN THE USE OF HUMAN SUBJECTS FOR MEDICAL EXPERIMENTATION: A RE-EXAMINATION OF BASIC ISSUES , 1995 .

[4]  P. Estok,et al.  Research incentives: money versus gifts. , 1994, Nursing Research.

[5]  D W Vere,et al.  Payments to healthy volunteers--ethical problems. , 1991, British journal of clinical pharmacology.

[6]  R. Vrhovac,et al.  Drug trials on healthy volunteers in Yugoslavia. , 1990, International journal of clinical pharmacology, therapy, and toxicology.

[7]  T. F. Ackerman An ethical framework for the practice of paying research subjects. , 1989, IRB.

[8]  D. Vere Research on healthy volunteers--a report of the Royal College of Physicians. , 1987, British journal of clinical pharmacology.

[9]  J. Harry Research on healthy volunteers: a report of the Royal College of Physicians. , 1987, Journal of the Royal College of Physicians of London.

[10]  D. J. Gray,et al.  SUDDEN DEATH OF A VOLUNTEER , 1985, The Lancet.

[11]  Whinnery Je Motivational analysis of human volunteers for centrifuge acceleration research. , 1982 .

[12]  L Lasagna,et al.  Free‐living volunteer's motivations and attitudes toward pharmacologic studies in man , 1977, Clinical pharmacology and therapeutics.

[13]  Andrew G. Dean,et al.  Epi info, version 6 : a word-processing, database, and statistics program for public health on IBM-compatible microcomputers , 1996 .

[14]  Searight Hr,et al.  Remembering and Interpreting Informed Consent: A Qualitative Study of Drug Trial Participants , 1996, The Journal of the American Board of Family Medicine.

[15]  L. D. de Castro Exploitation in the use of human subjects for medical experimentation: a re-examination of basic issues. , 1995, Bioethics.

[16]  J. E. Whinnery Motivational analysis of human volunteers for centrifuge acceleration research. , 1982, Aviation, space, and environmental medicine.